HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Therapeutic strategies for advanced respectable esophageal cancer].

Abstract
There are obvious differences in the clinical characteristics of patients with advanced respectable esophageal cancer between Japan and Western countries. In Japan, more than 90% of patients with esophageal cancer are histologically diagnosed with squamous cell carcinoma. On the other hand, the incidence of esophageal adenocarcinoma is rapidly increasing in the West. As a standard surgical approach, relatively invasive transthoracic extended esophagectomy has been established in Japan since the 1980s and has contributed to improved long-term survival of patients with squamous cell carcinoma. The current standard care for resectable stage II/III esophageal squamous cell carcinoma is neoadjuvant chemotherapy with 5-fluorouracil/cisplatin and radical esophagectomy based on the results of Japan Clinical Oncology Group trial 9907. In the West, relatively less invasive transhiatal esophagectomy with limited lymph node dissection has played a role in the multidisciplinary treatment of esophageal adenocarcinoma. Recently, a multimodal approach to esophageal cancer treatment including definitive chemoradiotherapy has been a focus of attention in both Japan and the West. For the further improvement of long-term survival of patients with esophageal cancer, the optimization of multimodal treatments and establishment of a global standard are essential.
AuthorsYuko Kitagawa
JournalNihon Geka Gakkai zasshi (Nihon Geka Gakkai Zasshi) Vol. 109 Issue 6 Pg. 333-7 (Nov 2008) ISSN: 0301-4894 [Print] Japan
PMID19068714 (Publication Type: Comparative Study, English Abstract, Journal Article)
Topics
  • Adenocarcinoma (pathology, therapy)
  • Carcinoma, Squamous Cell (pathology, therapy)
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Esophageal Neoplasms (pathology, therapy)
  • Esophagectomy
  • Europe
  • Humans
  • Japan
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Radiotherapy, Adjuvant
  • Salvage Therapy
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: